Nasdaq · Healthcare
Orthofix Medical Inc. (OFIX)
As-reported financials and recent SEC filings for Orthofix Medical Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$822.3M
Net income
$-92.2M
Net margin
-11.2%
Diluted EPS
$-2.33
ROE
-20.5%
P/E (TTM)
—
Market cap
$395.3M
Debt / equity
0.3×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $822.3M | $799.5M | $746.6M | $460.7M | $464.5M |
| Gross profit | $566.0M | $545.9M | $486.3M | $337.2M | $349.6M |
| Operating income | $-81.4M | $-84.6M | $-139.1M | $-13.3M | $-8.3M |
| Net income | $-92.2M | $-126.0M | $-151.4M | $-19.7M | $-38.4M |
| Diluted EPS | $-2.33 | $-3.30 | $-4.12 | $-0.98 | $-1.95 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-22
View on EDGAR →42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →Go deeper on OFIX
Search Orthofix Medical Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.